FOXP3 and hepatocellular carcinoma: In particular, a high CD8+/Foxp3+CD4+ T cells ratio has been associated with favorable disease outcome in ovarian and hepatocellular carcinoma patients [30, 41] and with a poor prognosis in subjects affected by head and neck cancer [42].